17.05.2015 Views

14-1190b-innovation-managing-risk-evidence

14-1190b-innovation-managing-risk-evidence

14-1190b-innovation-managing-risk-evidence

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

38<br />

CASE STUDY<br />

CONSISTENCY AND TRANSPARENCY IN EVIDENCE-BASED<br />

REGULATION: RISK AND PRECAUTION IN THE REGULATION<br />

OF BISPHENOL A<br />

Patrick Miller (Food Standards Agency)<br />

Regulators often need to review and adapt<br />

regulations as the <strong>evidence</strong> on <strong>risk</strong>s develops.<br />

But if they are to maintain credibility and<br />

trust, they must handle this process in a consistent<br />

and transparent way, and always explain the rationale<br />

for their <strong>risk</strong>-management decisions. They should<br />

clearly distinguish between hazard and <strong>risk</strong>; between<br />

the uncertainties addressed directly within a <strong>risk</strong><br />

assessment, and wider uncertainties that may pertain<br />

to the <strong>risk</strong> management decision; and consider the<br />

unintended consequences of any new measures. The<br />

case of bisphenol A (BPA) illustrates some of the<br />

challenges of this approach.<br />

BPA is a chemical used to make plastics, including<br />

those used as protective coatings and linings for food<br />

and drinks cans, and also in some refillable<br />

drinks bottles and food storage containers.<br />

Minute amounts of BPA can transfer<br />

from these materials into food and<br />

drinks. For plastic food-contact<br />

materials, EU legislation sets limits for<br />

the amount of BPA that can migrate<br />

into food. These ensure consumer<br />

exposure remains within guidelines<br />

established by independent expert <strong>risk</strong><br />

assessments.<br />

There is some <strong>evidence</strong> that BPA interacts<br />

with hormone systems and may act as an endocrine<br />

disruptor. Consequently its safety has been reviewed<br />

several times to assess whether these potential effects<br />

are relevant for human exposure to BPA. The European<br />

Food Safety Authority (EFSA) began its most recent<br />

comprehensive review of BPA in 2012, and consulted<br />

on two parts of its draft opinion in 2013 and 20<strong>14</strong>;<br />

its final opinion is due later in 20<strong>14</strong>. The draft EFSA<br />

opinion proposes a revised exposure guideline for<br />

BPA and concludes that exposures to BPA are below<br />

this level for consumers in all age groups. EFSA’s<br />

initial finding is thus that the health concern for all<br />

population groups is low 1 .<br />

rigorous assessment of the balance of <strong>evidence</strong>,<br />

and an understanding of how any changes will<br />

achieve an improvement in consumer protection in<br />

a proportionate way, while guarding against adverse<br />

unintended consequences. The UK Committee on<br />

Toxicity of Chemicals in Food, Consumer Products<br />

and the Environment (COT) has concluded that the<br />

draft EFSA opinion does not indicate a <strong>risk</strong> to UK<br />

consumers from dietary exposure to BPA 2 . The FSA<br />

will also assess the final EFSA opinion and review the<br />

need for any further action, working with the European<br />

Commission and EU member states 3 .<br />

Some EU member states have already introduced or<br />

announced plans for more restrictive controls on BPA,<br />

which are described as ‘precautionary’. This raises a<br />

number of issues:<br />

1. Acting in advance of, or contrary to,<br />

an EFSA opinion <strong>risk</strong>s undermining<br />

the process of <strong>risk</strong>-based decision<br />

making in the European Union.<br />

2. According a communication<br />

from the European Commission, the<br />

‘precautionary principle’ should not be<br />

used to cope with uncertainties that<br />

are dealt with during a <strong>risk</strong> assessment,<br />

but only when there are wider, more<br />

fundamental <strong>evidence</strong> gaps 4 .<br />

3. Use of precaution should not be one-sided.<br />

Regulators need to consider the balance of <strong>risk</strong>s and<br />

benefits, and the associated uncertainties, that are<br />

caused by a ‘precautionary’ action, and compare that<br />

with the effects of maintaining the status quo. This<br />

includes a consideration of unintended consequences<br />

— for example, problems with the safety and<br />

effectiveness of replacements for BPA.<br />

4. Decision-makers may of course take other factors<br />

into account, and do not have to rely solely on the<br />

<strong>risk</strong> assessment — but when they do so, they should<br />

set out their rationale and the supporting <strong>evidence</strong><br />

transparently.<br />

Regulatory responses to the revised EFSA <strong>risk</strong><br />

assessment<br />

The UK Food Standards Agency (FSA) is clear that<br />

any change in BPA controls should be based on a<br />

The FSA is working with the network of national food<br />

agencies in Europe to try to develop principles and<br />

tools to improve consistency and transparency in this<br />

process 5 .

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!